In 2024, Drehstrom Filmproduktion produced two image films for PULMONX INTERNATIONAL that highlight therapy with endobronchial valves (EBV) for pulmonary emphysema.
Eberhard Jordan: When I think back to the time before I got the valves and could barely make it up the two flights of stairs to my apartment, what I’m doing now feels like a small miracle — a real wow effect for me. Climbing the DC Tower, that was quite a big deal. That building is just massive and incredibly tall. We trained for it intensely for a long time, and during the climb itself, by the time I reached the 40th floor, I knew I had made it.My name is Eberhard Jordan. I am a visual artist, COPD activist, and author — and a valve recipient.
Prim. Dr. Valipour: My name is Arschang Valipour. I’m a pulmonologist and internist at Floridsdorf Clinic in Vienna. I’ve been treating patients with COPD for around 25 years.
Dr. Petrovic: My name is Milos Petrovic. I’m a pulmonologist in Vienna and have had my own practice for three years. In addition, I work in outpatient rehabilitation at Therme Wien Med.
Prim. Dr. Valipour: So, what were the main symptoms of COPD and emphysema before treatment with the valves took place?
Eberhard Jordan: The main symptoms were that I could barely climb stairs anymore — let alone walk behind someone or keep up with them. Carrying groceries — I experienced extreme shortness of breath. When I got agitated, I could hardly breathe. These were the everyday struggles.
Prim. Dr. Valipour: How did you learn about valve therapy for treating emphysema?
Eberhard Jordan: I actually learned about Zephyr® valves indirectly. At the time, I was already considering: what about a transplant? And during all that research, I met a doctor who told me about Zephyr valves and said: “Give it a try — maybe it’ll work.”
Prim. Dr. Valipour: What treatment options are available when COPD has progressed this far?
Dr. Petrovic: Of course, we try every medication, every inhaler available, increasing both strength and dosage. A second key component is rehabilitation. Unfortunately, once we’ve exhausted those options and the patient still doesn’t improve, our hands are tied. Then, we have to consider whether a minimally invasive procedure — like valve implantation — might be appropriate, or even a major surgery. And that would be lung transplantation.
Prim. Dr. Valipour: Valve implantation is a method to improve lung function in people with severe emphysema. You underwent this procedure.
Eberhard Jordan: Yes, though I should say it wasn’t just one valve implantation — I had three attempts. The first time, the results were incredible, very quick, and I was overjoyed. But that success faded quickly. Then we both decided: “Okay, let’s try a second round.” Again, great results — but suddenly it dropped back to the previous level. And then came the third attempt — and that’s been working wonderfully for seven years now.
Prim. Dr. Valipour: There can be various reasons for that. We also talked about it back then. For example, valves can shift or not sit quite as well as they should. In the vast majority of cases, though, it works the first time.What impact did the therapy have on your quality of life?
Eberhard Jordan: Everyday activities became easier because I felt safer, because I had more lung capacity. I was able to train more — and that was personally very important to me.I set myself the challenge: “Okay, Vienna has several towers — and I want to climb those towers, just because I know how hard it is to climb even to the second floor when you have COPD.”And I tell everyone: the DC Tower is not the real measure. The real measure is making it to the second or third floor.
Prim. Dr. Valipour: I think we can both say, as the treating pulmonologists, that Mr. Jordan has truly achieved something remarkable — thanks to consistent medication therapy, valve therapy, and, above all, very consistent training, which made such an achievement possible in the first place.So, what challenges are you planning to take on next, and how are you doing at the moment?
Eberhard Jordan: Right now, I’m feeling very stable, and I’m already looking forward to getting back on my bike and tackling 44 kilometers on the Danube Island. That’s my next challenge.
Pulmonx International is a world-leading medical technology company based in Neuchâtel, Switzerland, specializing in interventional pulmonology and the treatment of obstructive lung diseases. As a subsidiary of Pulmonx Corporation, headquartered in Redwood City, California, the company develops and distributes innovative solutions for patients with severe emphysema.
Pulmonx’s main product is the Zephyr® Endobronchial Valve – a minimally invasive implant that is placed via bronchoscopy to block overinflated areas of the lung. This allows healthier lung tissue to expand more effectively, making breathing easier and significantly improving patients’ quality of life.
A key priority for Pulmonx is making patient experiences visible. To this end, the company regularly publishes video portraits of individuals who have been treated with Zephyr valves. These patient stories compellingly illustrate how people are able to resume everyday activities after the procedure – such as climbing stairs, cycling, or playing with their grandchildren. The videos are available on Pulmonx’s official website as well as on platforms like YouTube and Facebook.
In this video, artist and COPD activist Eberhard Jordan shares how he came to receive his Zephyr® valves from Pulmonx and how they have helped him improve his quality of life.
Dr. Petrovic: Approximately 20% of patients are severely ill, for whom medication and rehabilitation yield hardly any success. This group of patients may be suitable for valve implantation or lung transplantation.
Prim. Dr. Valipour: The goal of valve therapy for pulmonary emphysema is what's known as lung volume reduction—treatment that was previously performed surgically, but is now possible using a minimally invasive bronchoscopic method. The insertion of small, one-way implants and valves into the affected airways, leading to the most hyperinflated areas of the emphysema, aims to block inspiration and thereby prevent airflow into these diseased sections of the lung. However, exhalation—breathing out—remains possible. This leads to a gradual reduction in volume and an improvement in diaphragm muscle function. Ventilation is redirected to better-perfused lung areas, resulting in improved breathing mechanics, which ultimately leads to enhanced quality of life, better lung function, and increased physical capacity.
Dr. Petrovic: In my practice, I’ve implemented a protocol for assessing suitability for valve therapy—lung volume reduction therapy—for severely ill patients, based on specific criteria. These include pulmonary function parameters such as total lung capacity, residual volume, and forced expiratory volume in one second, as well as the presence of emphysema confirmed by a CT scan. If these conditions are met, the patient is referred to the center, where it is determined whether they are truly suitable for the therapy. Patients are informed in advance that meeting all the criteria in my practice does not automatically mean they qualify for this treatment.
Prim. Dr. Valipour: Evaluating a patient’s eligibility for valve therapy involves several preliminary tests, all of which are non-invasive. These include a questionnaire, pulmonary function testing, and a non-contrast CT scan. In individual cases, further assessments such as a cardiac ultrasound, medication review, and symptom evaluation may also be conducted. This allows for accurate patient selection, ensuring that those who are most likely to benefit from valve therapy actually receive it. Valve therapy is now a well-established treatment that we routinely perform.
Dr. Petrovic: The outcomes of valve implantation therapy in the patients I see in my practice are consistently positive. We can generally expect that their pulmonary hyperinflation is significantly reduced. As a result, they can breathe more easily, experience less shortness of breath, and become more physically active, with an overall improvement in their quality of life. Even achieving this in a small percentage of patients is considered a success. I explain the valve implantation procedure to patients by drawing it out. Although I have informational materials, I try to visually demonstrate to patients that the overinflated areas of their lungs—where no gas exchange is taking place—are sealed off using these valves. Fortunately, if the treatment doesn’t work or complications arise, the valves can also be removed. It’s a method that can be reversed if needed.
Prim. Dr. Valipour: Care for COPD and emphysema patients is primarily handled by their respective pulmonologists. These specialists are the central coordinators when it comes to referring patients for specialized therapies like valve treatment. In follow-up care, it is also essential that patients we have treated are returned to the care of their pulmonologists. Therefore, mutual exchange and good communication are indispensable.
Dr. Petrovic: Simply consider lung volume reduction therapy as an option—and refer the patient to the center.
In this video pulmonologists Prim. Dr. Valipour and Dr. Petrovic explain how the therapy with endobronchial valves works, which patients are eligible and how the path to the therapy works for patients and lung specialists.
Want to see more previously produced videos, films, and animations by Drehstrom Filmproduktion?
Would you like to learn more examples of the successful use of video marketing?
Want to know more about Drehstrom Filmproduktion’s way of working and pricing?
Looking for advice on your video marketing or need a video or animated film?